Quimiging, Rosalinda D.
HRN: 29-33-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
CEFTRIAXONE 1G (VIAL)
07/20/2026
07/27/2026
IV
2g
OD
Uti
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes